Safety and efficacy of GP40061 compared with originator insulin glargine (Lantus ®): a randomized open-label clinical trial.
Conclusion: GP-Gla and Sa-Gla demonstrated similar safety and efficacy. ClinicalTrials.gov Identifier: NCT04022993.
PMID: 32027167 [PubMed - as supplied by publisher]
Source: Journal of Comparative Effectiveness Research - Category: General Medicine Tags: J Comp Eff Res Source Type: research
More News: Clinical Trials | Diabetes | Diabetes Mellitus | Diabetes Type 1 | Endocrinology | General Medicine | Insulin | Lantus